{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:05:50Z","timestamp":1788285950537,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"GlaxoSmithKline (GSK) Japan Research Grant 2016","award":["D14"],"award-info":[{"award-number":["D14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00345-020-03095-1","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T15:02:42Z","timestamp":1580310162000},"page":"2915-2921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Higher expression of phosphodiesterase type 5 in the anterior fibromuscular stroma of the human prostate"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-1101","authenticated-orcid":false,"given":"Tsuyoshi","family":"Iwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ukimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"issue":"4","key":"3095_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","volume":"60","author":"M Gacci","year":"2011","unstructured":"Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG (2011) Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 60(4):809\u2013825","journal-title":"Eur Urol"},{"issue":"1","key":"3095_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1743-6109.2004.10104.x","volume":"1","author":"TF Lue","year":"2004","unstructured":"Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsh M, Kimoto M, Lewis R, Mckenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G (2004) Summary of the recommendations on sexual dysfunctions in men. J Sex Med 1(1):6\u201323","journal-title":"J Sex Med"},{"issue":"3","key":"3095_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","volume":"177","author":"KT McVary","year":"2007","unstructured":"McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G (2007) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177(3):1071\u20131077","journal-title":"J Urol"},{"issue":"2","key":"3095_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/bbrc.1998.8769","volume":"247","author":"P Stacey","year":"1998","unstructured":"Stacey P, Rulten S, Dapling A, Phillips SC (1998) Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 247(2):249\u2013254","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3095_CR5","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1210\/en.2003-1699","volume":"145","author":"A Morelli","year":"2004","unstructured":"Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannneli GB, Aversa A, Natali A, Forti G, Giogi M, Jannini EA, Ledda F, Maggi M (2004) Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 145(5):2253\u20132263","journal-title":"Endocrinology"},{"issue":"6","key":"3095_CR6","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/S0022-5347(05)65621-2","volume":"166","author":"S \u00dcckert","year":"2001","unstructured":"\u00dcckert S, Kuthe A, Jonas U, Stief CG (2001) Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166(6):2484\u20132490","journal-title":"J Urol"},{"key":"3095_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/en.2006-1079","volume":"148","author":"S Filippi","year":"2007","unstructured":"Filippi S, Morelli A, Sandner P et al (2007) Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 148:1019\u20131029","journal-title":"Endocrinology"},{"key":"3095_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.eururo.2005.12.050","volume":"49","author":"S \u00dcckert","year":"2006","unstructured":"\u00dcckert S, Oelke M, Stief CG et al (2006) Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol 49:740\u2013745","journal-title":"Eur Urol"},{"issue":"8","key":"3095_CR9","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/en.2009-1411","volume":"151","author":"C Zenzmaier","year":"2010","unstructured":"Zenzmaier C, Sampson N, Pernkopf D, Plas E, Untergasser G, Berger P (2010) Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia. Endocrinology 151(8):3975\u20133984","journal-title":"Endocrinology"},{"issue":"6","key":"3095_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0022-5347(17)61195-9","volume":"107","author":"JE McNeal","year":"1972","unstructured":"McNeal JE (1972) The prostate and prostatic urethra: a morphologic synthesis. J Urol 107(6):1008\u20131016","journal-title":"J Urol"},{"key":"3095_CR11","first-page":"340","volume":"15","author":"JE McNeal","year":"1978","unstructured":"McNeal JE (1978) Origin and evolution of benign prostatic enlargement. Investig Urol 15:340\u2013345","journal-title":"Investig Urol"},{"issue":"4","key":"3095_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/pros.1103","volume":"48","author":"T Iwata","year":"2001","unstructured":"Iwata T, Ukimura O, Inaba M, Kojima M, Kumamoto K, Ozawa H, Kawata M, Miki T (2001) Immunohistochemical studies on the distribution of nerve fibers in the human prostate with special reference to the anterior fibromuscular stroma. Prostate 48(4):242\u2013247","journal-title":"Prostate"},{"issue":"5","key":"3095_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ultrasmedbio.2004.02.005","volume":"30","author":"O Ukimura","year":"2004","unstructured":"Ukimura O, Iwata T, Ushijima S, Suzuki K, Honjo H, Okihara K, Mizutani Y, Kawauchi A, Miki T (2004) Possible contribution of prostatic anterior fibromuscular stroma to age-related urinary disturbance in reference to pressure-flow study. Ultrasound Med Biol 30(5):575\u2013581","journal-title":"Ultrasound Med Biol"},{"key":"3095_CR14","doi-asserted-by":"crossref","unstructured":"Ehrlich Y, Foster RS, Bihrle R, Cheng L, Tong Y, Koch MO (2010) Division of prostatic anterior fibromuscular stroma reduces urethral resistance in an ex vivo human prostate model. Urology 76(2):511 e10\u20133","DOI":"10.1016\/j.urology.2010.03.035"},{"issue":"7","key":"3095_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/iju.12413","volume":"21","author":"K Nishio","year":"2014","unstructured":"Nishio K, Soh S, Syukuya T, Sato R, Sadaoka Y, Iwahata T, Suzuki K, Ashizawa Y, Kobori Y, Okada H (2014) Role of male pelvic floor muscles and anterior fibromuscular stroma in males on alpha(1)-blocker treatment: a magnetic resonance imaging study. Int J Urol 21(7):724\u2013727","journal-title":"Int J Urol"},{"issue":"5","key":"3095_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/002215540004800512","volume":"48","author":"J Kotera","year":"2000","unstructured":"Kotera J, Fujishige K, Omori K (2000) Immunohistochemical Localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues. J Histochem Cytochem 48(5):685\u2013693","journal-title":"J Histochem Cytochem"},{"key":"3095_CR17","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0022-5347(01)66779-X","volume":"154","author":"SA Kaplan","year":"1995","unstructured":"Kaplan SA, Te AE, Pressler LB, Olsson CA (1995) Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J. Urol 154:1764\u20131769","journal-title":"J. Urol"},{"key":"3095_CR18","doi-asserted-by":"publisher","first-page":"17888","DOI":"10.1038\/srep17888","volume":"5","author":"W Zhang","year":"2015","unstructured":"Zhang W, Zang N, Jiang Y, Chen P, Wang X, Zhang X (2015) Upregulation of phosphodiesterase type 5 in the hyperplastic prostate. Sci Rep 5:17888","journal-title":"Sci Rep"},{"key":"3095_CR19","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/j.1464-410X.2010.09759.x","volume":"107","author":"C Zhao","year":"2011","unstructured":"Zhao C, Kim SH, Lee SW et al (2011) Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int 107:1943\u20131947","journal-title":"BJU Int"},{"key":"3095_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00345-013-1048-9","volume":"31","author":"S \u00dcckert","year":"2013","unstructured":"\u00dcckert S, Waldkirch ES, Merseburger AS et al (2013) Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide\/cyclic GMP signaling in the human prostate. World J Urol 31:609\u2013614","journal-title":"World J Urol"},{"key":"3095_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","volume":"63","author":"F Giuliano","year":"2013","unstructured":"Giuliano F, \u00dcckert S, Maggi M et al (2013) The mechanism of action of phosphodiesterase type 5 (PDE5) inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Eur Urol 63:506\u2013516","journal-title":"Eur Urol"},{"issue":"1","key":"3095_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1743-6109.2009.01511.x","volume":"7","author":"B Fibbi","year":"2010","unstructured":"Fibbi B, Morelli A, Vignozzi L et al (2010) Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med 7(1):59\u201369","journal-title":"J Sex Med"},{"issue":"1","key":"3095_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12728","volume":"115","author":"M Gacci","year":"2015","unstructured":"Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, Tubaro A, Oelke M, Carini M, Maggi M (2015) Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int 115(1):24\u201331","journal-title":"BJU Int"},{"issue":"13","key":"3095_CR24","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/pros.22686","volume":"73","author":"L Vignozzi","year":"2013","unstructured":"Vignozzi L, Gacci M, Cellai I, Morelli A, Maneschi E, Comeglio P, Santi R, Filippi S, Sebastianelli A, Nesi G, Serni S, Carini M, Maggi M (2013) PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS. Prostate 73(13):1391\u20131402","journal-title":"Prostate"},{"issue":"4","key":"3095_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/pros.22584","volume":"73","author":"A Morelli","year":"2013","unstructured":"Morelli A, Comeglio P, Filippi S, Sarchielli E, Vignozzi L, Maneschi E, Cellai I, Gacci M, Lenzi A, Vannelli GB, Maggi M (2013) Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit. Prostate 73(4):428\u2013441","journal-title":"Prostate"},{"issue":"4","key":"3095_CR26","first-page":"360","volume":"18","author":"T Iwata","year":"1999","unstructured":"Iwata T, Ukimura O, Kojima M, Ozawa H, Kawata M, Miki T (1999) Age-related increase of the connective tissue in the anterior fibromuscular stroma of the prostate. Neurourol Urodyn 18(4):360","journal-title":"Neurourol Urodyn"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-020-03095-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:18:15Z","timestamp":1611793095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-020-03095-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03095-1","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"12 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}